Passage Bio Inc (PASG)

Finanzdaten der Passage Bio Inc-Aktie (PASG)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Income/Loss	35.67% -18.45	-28.67	-25.39	-35.88	-28.24
Income/Loss From Continuing Operations Before Tax	38.19% -16.76	-27.11	-23.86	-34.34	-27.07
Income/Loss From Continuing Operations After Tax	38.19% -16.76	-27.11	-23.86	-34.34	-27.07
Net Income/Loss	38.19% -16.76	-27.11	-23.86	-34.34	-27.07
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.92% 0.0455	54.79	54.68	54.62	0.0496
Diluted Average Shares	99.92% 0.0455	54.79	54.68	54.62	0.0496
Basic Earnings Per Share	38.78% -0.30	-0.49	-0.44	-0.63	-0.49
Diluted Earnings Per Share	38.78% -0.30	-0.49	-0.44	-0.63	-0.49
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-